Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 27, 2016JAMA OncologyOpen Access

Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

KCKarim ChamieNDNicholas M. DoninPKPia Klöpfer

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chamie et al. (2016) studied this question.

synapsesocial.com/papers/69ffbb2d2ff633f36577a9adhttps://doi.org/10.1001/jamaoncol.2016.4419
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Impact of Age on the Response of Patients With Superficial Bladder Cancer to Intravesical Immunotherapy2006 · 154 citations
  2. 2Risk Group Assessment and Clinical Outcome Algorithm to Predict the Natural History of Patients With Surgically Resected Renal Cell Carcinoma2002 · 678 citations
  3. 3Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.1993 · 183 citations
  4. 4Optimization of Immunotherapy in Elderly Cancer Patients2013 · 59 citations